Literature DB >> 11596782

Pure motor chronic inflammatory demyelinating polyneuropathy.

M Sabatelli1, F Madia, T Mignogna, G Lippi, L Quaranta, P Tonali.   

Abstract

We describe four patients affected by chronic inflammatory demyelinating polyneuropathy (CIDP) in a pure motor form. Selective involvement of motor fibers was suggested by the absence of sensory symptoms, normal sensation at neurological examination and normal findings on electrophysiological testing of sensory fibres and sural nerve biopsy. The onset of the disease occurred at a young age (3-29 years) and the clinical course was relapsing-remitting. Over a follow-up period of 1.5-14 years, periodical clinical and electrophysiological examinations showed that selective involvement of motor fibers remained a constant feature. Electromyography and nerve conduction studies continued to show a purely demyelinating neuropathy without signs of axonal impairment. All patients were steroid-unresponsive, whereas they considerably improved after being treated with immunoglobulins. Two patients were treated with interferon alpha and showed a good response. In conclusion, the occurrence in our four patients of pure motor involvement over a long period of time during which several relapses occurred, suggests that pure motor CIDP may represent the result of a specific immunological process rather than of a random distribution of inflammation throughout peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596782     DOI: 10.1007/s004150170093

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

Review 1.  Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.

Authors:  David S Saperstein; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

2.  Electrophysiological predictors of steroid-responsiveness in chronic inflammatory demyelinating polyneuropathy.

Authors:  Y A Rajabally; M Narasimhan; G Chavada
Journal:  J Neurol       Date:  2008-04-30       Impact factor: 4.849

Review 3.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard Ac Hughes; Man Mohan Mehndiratta; Yusuf A Rajabally
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

Review 4.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

5.  Motor-dominant chronic inflammatory demyelinating polyneuropathy.

Authors:  Akio Kimura; Takeo Sakurai; Akihiro Koumura; Megumi Yamada; Yuichi Hayashi; Yuji Tanaka; Isao Hozumi; Hiide Yoshino; Tatsuhiko Yuasa; Takashi Inuzuka
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

6.  Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.

Authors:  M Odaka; M Tatsumoto; K Susuki; K Hirata; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

7.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

8.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

9.  Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.

Authors:  Naruemon Bamrungsawad; Nilawan Upakdee; Chayanin Pratoomsoot; Rosarin Sruamsiri; Piyameth Dilokthornsakul; Supinya Dechanont; David Bin-Chia Wu; Charungthai Dejthevaporn; Nathorn Chaiyakunapruk
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

Review 10.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.